Hitto Kaufmann's Insider Trades & SAST Disclosures

Hitto Kaufmann's most recent trade in Pieris Pharmaceuticals Inc was a trade of 249,080 Stock Option (Right to buy) done . Disclosure was reported to the exchange on Feb. 24, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Pieris Pharmaceuticals Inc
Hitto Kaufmann Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2023 249,080 249,080 - - Stock Option (Right to buy)
Pieris Pharmaceuticals Inc
Hitto Kaufmann SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 215,819 215,819 - - Stock Option (Right to buy)
Pieris Pharmaceuticals Inc
Hitto Kaufmann SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 220,000 220,000 - - Stock Options (Right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades